繁体中文
设为首页
加入收藏
当前位置:药品说明书与价格首页 >> 皮肤性病 >> 新药动态 >> 带状疱疹新药—Qutenza(辣椒素)8%透皮贴剂FDA批准上市

带状疱疹新药—Qutenza(辣椒素)8%透皮贴剂FDA批准上市

2011-01-26 23:43:52  作者:新特药房  来源:中国新特药网天津分站  浏览次数:410  文字大小:【】【】【
简介: FDA批准Qutenza用于缓解带状疱疹引起的长期疼痛 美国食品药品管理局(FDA)近日已批准德国Lohmann Therapie-Systems公司的Qutenza(辣椒碱)8%贴剂上市。这种外用皮肤贴剂可用于缓解疱疹后神经痛(PHN ...

FDA批准Qutenza用于缓解带状疱疹引起的长期疼痛

美国食品药品管理局(FDA)近日已批准德国Lohmann Therapie-Systems公司的Qutenza(辣椒碱)8%贴剂上市。这种外用皮肤贴剂可用于缓解疱疹后神经痛(PHN)——一种带状疱疹发病后的常见严重并发症。

带状疱疹会使患者皮肤上出现大量红疹或水疱。与水痘相同,带状疱疹也是由水痘-带状疱疹病毒引起的。这种病毒可能会在初次感染的数年后再次活化,因此曾患水痘的人群更易出现带状疱疹症状。PHN会对神经纤维和皮肤产生影响,从而引起长达数周、数月甚至数年的剧烈疼痛。大约10%~15%的带状疱疹患者都曾遭受过PHN,这种并发症在老年患者中尤为常见。

临床研究已显示,疼痛部位贴上Qutenza仅1h后PHN疼痛即可减少,效力能持续达12周。可以使用达4贴,并可根据疼痛区域的大小和形状对贴片进行相应的剪切。Qutenza贴剂治疗可以每3个月或3个月以上重复一次,这视疼痛的复发时间而定。

在临床试验中,Qutenza最常见的不良反应为用药部位发红、疼痛、发痒以及丘疹。其中大多数不良反应呈暂时性和自限性。在接受Qutenza治疗的患者中,有1%因不良反应而提前终止治疗。严重的不良反应包括用药部位疼痛和血压升高。血压升高发生于应用Qutenza过程中或接触此贴剂后不久。某些患者的血压出现较大幅度的上升,但平均变化值为60;10 mmHg。在去除贴剂后血压变化持续约2 h。

Qutenza中含有辣椒碱(一种存在于辣椒中的成分)。虽然目前市场上已有含低浓度辣椒碱的OTC产品用于治疗PHN,但Qutenza是首个经FDA批准的,含有高浓度合成纯辣椒碱的处方药。

Neurogesx公司拟于2010年上半年将Qutenza推向美国市场。

QUTENZA

Indications for QUTENZA

Management of neuropathic pain associated with post-herpetic neuralgia.

Adult dose for QUTENZA

Identify treatment area and mark the skin; may cut patches to match size and shape of area. Pretreat with topical anesthetic to reduce discomfort, once anesthetized, remove anesthetic and wash the treatment area. Apply to dry, intact skin within 2 hours of opening patch. Apply patch (up to 4 may be used) for 60 minutes, repeat every 3 months or as warranted by the return of pain (not more frequently than every 3 months). May use a dressing to ensure patch remains in contact with treatment area. After removal of patch, apply Cleansing Gel to area and leave on for at least one minute. Remove Cleansing Gel with dry wipe; wash and dry the area. Treat acute pain during and following the procedure with local cooling and/or analgesics. Use nitrile gloves when handling patch and cleaning capsaicin residue from skin. Immediately dispose of patches.

Children's dosing for QUTENZA

<18yrs: not recommended.

Warnings/Precautions for QUTENZA

Should only be administered by a physician or healthcare professional. Aerosolization of capsaicin may occur with rapid removal of patches, remove patches slowly by rolling the adhesive side inward. Avoid exposure to eyes, mucous membranes. Evaluate for recent history of cardio- and cerebrovascular disease. Monitor BP periodically during treatment. Pregnancy (Cat.B). Nursing mothers; do not breastfeed after treatment on the day of treatment.

Adverse Reactions for QUTENZA

Application site reactions (eg, erythema, pain, pruritus, papules); increased blood pressure.

How is QUTENZA supplied?

Patch—1, 2 (both with 50g tube of Cleansing Gel)

Related Disease:

Postherpetic neuralgia~topical analgesics/anesthetics

责任编辑:admin


相关文章
加巴喷丁缓释片|Horizant(Gabapentin Enacarbil Tablets)
FDA批准Qutenza用于缓解带状疱疹引起的长期疼痛
辣椒素透皮贴剂|Qutenza(Capsaicin Patch)
辣椒素透皮贴剂| Qutenza(Capsaicin Patch)
泛昔洛韦片|FAMVIR(FAMCICLOVIR)
Qutenza(辣椒碱)8%贴剂
泛昔洛韦与阿昔洛韦治疗带状疱疹疗效观察
治疗带状疱疹神经痛“乐瑞卡”2010年国内最新上市
伐昔洛韦之阿迈新与明竹欣效果比较
西黄丸外涂的中西结合治疗老年2型糖尿病并带状疱疹
 

最新文章

更多

· 美国FDA批准各种HIV感染...
· FDA批准复方抗艾药Evota...
· 新型Reyataz(atazanavir...
· SCENESSE(afamelanotide...
· 银屑病新药Cosentyx(ust...
· Cosentyx(secukinumab)白...
· Otezla(apremilast)将获...
· 新重组单抗Cosentyx(sec...
· Soolantra(Ivermectin 1...
· 美国FDA批准Gardasil 9价...

推荐文章

更多

· 美国FDA批准各种HIV感染...
· FDA批准复方抗艾药Evota...
· 新型Reyataz(atazanavir...
· SCENESSE(afamelanotide...
· 银屑病新药Cosentyx(ust...
· Cosentyx(secukinumab)白...
· Otezla(apremilast)将获...
· 新重组单抗Cosentyx(sec...
· Soolantra(Ivermectin 1...
· 美国FDA批准Gardasil 9价...

热点文章

更多